Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008–2019

Background: Germany is a low prevalence country for hepatitis B virus (HBV) infection with higher prevalence in vulnerable groups. The number of treated chronic hepatitis B (CHB) patients is unknown. We aimed to determine the number of CHB patients treated with nucleos(t)ide analogs (NUCs), the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Maisa, Anna, Kollan, Christian, an der Heiden, Matthias, van Bömmel, Florian, Cornberg, Markus, Mauss, Stefan, Wedemeyer, Heiner, Schmidt, Daniel, Dudareva, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175796/
https://www.ncbi.nlm.nih.gov/pubmed/34095070
http://dx.doi.org/10.3389/fpubh.2021.667253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175796/
https://www.ncbi.nlm.nih.gov/pubmed/34095070
http://dx.doi.org/10.3389/fpubh.2021.667253

Ejemplares similares